IRBM
Business Services · Italy · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Via Pontina km 30,600, Pomezia, Latium, ...Phone Number
+39 691093692Website
www.irbm.comRevenue
$42.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About IRBM
IRBM is an integrated contract research organization headquartered in Pomezia, Italy, specializing in preclinical drug discovery across cancer, neurological disorders, infectious diseases, and rare diseases. Originally established in 1990 as a joint venture between Merck and Co. and Italian chemical company Sigma-Tau, IRBM became an independent drug discovery company in 2010, retaining the scientific team responsible for developing several marketed therapeutics including Isentress, Zolinza, Grazoprevir, and Zejula. The organization offers fully integrated drug discovery services spanning target identification and validation, hit finding, lead optimization, and clinical candidate nomination, working across modalities including small molecules, peptides, and antibodies. All research is conducted within a single, state-of-the-art facility designed to provide seamless transitions between disciplines. IRBM partners with pharmaceutical companies, biotech firms, and prominent research foundatRead more
IRBM Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IRBM your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if IRBM has recently received funding, and reach out quickly before it becomes old news!
IRBM, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if IRBM had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once IRBM has new funding data
Congratulate Masked Content for being promoted to Masked Content at IRBM
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on IRBM recently announced quarterly report
Check out if IRBM is spiking on competitors!
Product Launch: Get notified when IRBM launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
IRBM is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
IRBM is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about IRBM.
IRBM Tech Stack
A closer look at the technologies used by IRBM
Most Recent Scoops
Open Position
Open Position
Hiring Plans
IRBM has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
IRBM News & Media
IRBM Reports Breakthrough in Zika Virus Drug Discovery
ROME, Feb. 10, 2026 /PRNewswire/ -- IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough with the discovery of a novel and potent allosteric inhibitor targeting the Zika virus (ZIKV) protease (NS2B-NS3). The findings, published in Nature...IRBM Expands Functional Genomics Platform to Strengthen Early Drug Discovery
De-Risking Target Validation with Data-Driven Genomic Insights ROME, April 3, 2025 /PRNewswire/ -- IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target identification and validation, and generation of disease-relevant cellular models. The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellularIRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR
ROME, April 4, 2024 /PRNewswire/ -- IRBM, a leader in the field of drug discovery, announced today that it will be disclosing new data on two of its most promising internal assets at the upcoming American Association for Cancer Research (AACR) Annual Meeting occurring in San Diego, April...IRBM Expands Global Reach in Drug Discovery with New Boston Office
Strategic Growth and Increased Visibility Set to Enhance IRBM's Leadership Position ROME, March 5, 2024 /PRNewswire/ -- IRBM, an integrated drug discovery Contract Research Organization (CRO), announces its global expansion with a new office in Boston, Massachusetts, a cornerstone for...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IRBM
Sign Up For FreeTo access detailed company insights
IRBM is an integrated contract research organization headquartered in Pomezia, Italy, specializing in preclinical drug discovery across cancer, neurological disorders, infectious diseases, and rare diseases. Originally established in 1990 as a joint venture between Merck and Co. and Italian chemical company Sigma-Tau, IRBM became an independent dru... Read More
